Targeting HDAC9 Contributes to Degradation of MLL Fusion Oncoproteins in KMT2A-Rearranged Acute Myeloid Leukemia

被引：0
|
作者：
Zhou, Yutong [1 ]
Qian, Yu [1 ]
Jin, Jie [1 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Sch Med, Hangzhou, Peoples R China
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-185947
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
    Fechina, Larisa
    Popov, Alexander
    Tsaur, Grigory
    Henze, Guenter
    Shorikov, Egor
    Makarova, Olga
    Khlebnikova, Olga
    Zhukova, Yulia
    Arakaev, Oleg
    Streneva, Olga
    Verzhbitskaya, Tatiana
    Riger, Tatiana
    Solodovnikov, Alexander
    Lapotentova, Elena
    Aleinikova, Olga
    Myakova, Natalia
    Boichenko, Elmira
    Kondratchik, Konstantin
    Nikonova, Olga
    Shapochnik, Alexander
    Goroshkova, Marina
    Ponomareva, Natalia
    Novichkova, Galina
    Karachunskiy, Alexander
    Roumiantsev, Alexander
    LEUKEMIA, 2023, 37 (11) : 2276 - 2281
  • [42] Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in KMT2A-rearranged acute lymphoblastic leukemia: a case report and review of the literature
    Fournier, Elise
    Inchiappa, Luca
    Delattre, Carole
    Pignon, Jean-Michel
    Danicourt, Frederique
    Bemba, Maxime
    Roche-Lestienne, Catherine
    Daudignon, Agnes
    Decool, Gauthier
    Roumier, Christophe
    Dumezy, Florent
    Fournier, Loic
    Grardel, Nathalie
    Preudhomme, Claude
    Duployez, Nicolas
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1827 - 1830
  • [43] Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
    Larisa Fechina
    Alexander Popov
    Grigory Tsaur
    Guenter Henze
    Egor Shorikov
    Olga Makarova
    Olga Khlebnikova
    Yulia Zhukova
    Oleg Arakaev
    Olga Streneva
    Tatiana Verzhbitskaya
    Tatiana Riger
    Alexander Solodovnikov
    Elena Lapotentova
    Olga Aleinikova
    Natalia Myakova
    Elmira Boichenko
    Konstantin Kondratchik
    Olga Nikonova
    Alexander Shapochnik
    Marina Goroshkova
    Natalia Ponomareva
    Galina Novichkova
    Alexander Karachunskiy
    Alexander Roumiantsev
    Leukemia, 2023, 37 : 2276 - 2281
  • [44] HDAC8 Promotes MLL-Rearranged Acute Myeloid Leukemia By Inhibiting p53 Acetylation
    Wu, Dijiong
    Li, Man
    Zhang, Lianjun
    Qi, Jing
    Chen, Chun-Wei David
    He, Xin
    Zhu, Yinghui
    Dong, Haojie
    Sun, Jie
    Li, Ling
    Marcucci, Guido
    Kuo, Ya-Huei
    BLOOD, 2019, 134
  • [45] Blinatumomab with De-Escalated Chemotherapy for Infant KMT2A-Rearranged B-Cell Acute Lymphoblastic Leukemia
    Hodder, Angus
    Mishra, Avijeet Kumar
    Connor, Philip
    Cummins, Michelle
    Cheng, Danny
    Gattens, Michael
    Gibson, Brenda
    Ingham, Danielle
    Lindsay, Katherine
    Malone, Andrea
    Madni, Majid
    Moppett, John
    Motwani, Jayashree
    Patel, Pritesh
    Ramanathan, Subramaniam
    Roy, Anindita
    James, Beki
    Ancliff, Phil
    Vora, Ajay
    Bartram, Jack
    BLOOD, 2024, 144 : 2816 - 2817
  • [46] Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
    Cheung, Laurence C.
    Aya-Bonilla, Carlos
    Cruickshank, Mark N.
    Chiu, Sung K.
    Kuek, Vincent
    Anderson, Denise
    Chua, Grace-Alyssa
    Singh, Sajla
    Oommen, Joyce
    Ferrari, Emanuela
    Hughes, Anastasia M.
    Ford, Jette
    Kunold, Elena
    Hesselman, Maria C.
    Post, Frederik
    Faulk, Kelly E.
    Breese, Erin H.
    Guest, Erin M.
    Brown, Patrick A.
    Loh, Mignon L.
    Lock, Richard B.
    Kees, Ursula R.
    Jafari, Rozbeh
    Malinge, Sebastien
    Kotecha, Rishi S.
    LEUKEMIA, 2023, 37 (01) : 61 - 71
  • [47] Brachial plexus chloroma as a presenting feature of relapse in a child with KMT2A-rearranged acute lymphoblastic leukemia, a case report
    Pruitt, Jamie
    Flagg, Aron
    Hanna, Rabi
    Rotz, Seth J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (02) : 179 - 183
  • [48] Vorinostat and Bortezomib Combined Intensive Chemotherapy for Children with KMT2A (MLL)-rearranged Acute Lymphoblastic Leukemia
    Suzuki, Kyogo
    Muramatsu, Hideki
    Okuno, Yusuke
    Narita, Kotaro
    Kitazawa, Hironobu
    Huang, Yue
    Ichikawa, Daisuke
    Kataoka, Shinsuke
    Hamada, Motoharu
    Murakami, Norihiro
    Taniguchi, Rieko
    Kojima, Daiei
    Sekiya, Yuko
    Nishikawa, Eri
    Kawashima, Nozomu
    Narita, Atsushi
    Nishio, Nobuhiro
    Hama, Asahito
    Kojima, Seiji
    Takahashi, Yoshiyuki
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S90 - S90
  • [49] Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy
    Laurence C. Cheung
    Carlos Aya-Bonilla
    Mark N. Cruickshank
    Sung K. Chiu
    Vincent Kuek
    Denise Anderson
    Grace-Alyssa Chua
    Sajla Singh
    Joyce Oommen
    Emanuela Ferrari
    Anastasia M. Hughes
    Jette Ford
    Elena Kunold
    Maria C. Hesselman
    Frederik Post
    Kelly E. Faulk
    Erin H. Breese
    Erin M. Guest
    Patrick A. Brown
    Mignon L. Loh
    Richard B. Lock
    Ursula R. Kees
    Rozbeh Jafari
    Sébastien Malinge
    Rishi S. Kotecha
    Leukemia, 2023, 37 : 61 - 71
  • [50] Extramedullary relapse of KMT2A(MLL)-rearranged acute lymphoblastic leukemia with lineage switch following blinatumomab
    Aldoss, Ibrahim
    Song, Joo Y.
    BLOOD, 2018, 131 (22) : 2507 - 2507
12345